HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FSMA Re-inspection Fees MIA As Waiver Guidance Remains AWOL

This article was originally published in The Rose Sheet

Executive Summary

FDA will bill supplement and conventional food product firms $248 per hour for re-inspections in the US and $285 per hour outside the country in fiscal 2018, but as it has since Congress passed FSMA, the agency will not collect re-inspection and mandatory recall fees.

You may also be interested in...

‘Change Is Difficult’ But It’s A Must For US FDA's Food Program Culture, Expert Panel Advises

Expert panel notes overlap between cultural and structural changes, advises changes in both areas should be implemented together. Recommendations for culture changes include “commit to an on-going process of culture change from the highest levels of FDA leadership.”

Sheep Placenta Extract Supplement Firm Has Problems In Basement Facility

FDA warning identifies Perfect Choice/Nutricos Ceuticals as operating at a Lower Manhattan basement in a block with restaurants, massage parlors and other service businesses and boarded-up storefronts. As other own-labelers have done, it failed to conduct its own tests of products from contract manufacturer.

Budget Good For FDA Supplement Sector Oversight? Congress Wants To Know

A report submitted with appropriations legislation negotiated by conference committee and approved by both chambers instructs FDA to report to Congress about its activities and staffing for oversight of supplement manufacturers and marketers. In an indication members are aware of the scope of FDA's responsibilities in the sector, report also asks agency to provide information on work related to "manufacturers and marketers of products claiming to be dietary supplements."

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts